--- title: FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine | FDA description: On May 3, 2023, FDA approved the world’s first RSV vaccine for use in people aged 60 and older. Read more about promising news for infants and older adults image: https://blog.acutis.com/hubfs/blog-FDA%20approves%20first%20Respiratory%20Syncytial%20Virus%20(RSV)%20Vaccine%20copy%202.jpg --- [Skip to content](https://blog.acutis.com/fda-approves-first-respiratory-syncytial-virus-rsv-vaccine-fda#main-content) Close - About - [What is Acutis?](https://acutis-21140295.hs-sites.com/what-is-acutis) - [Our Team](https://acutis-21140295.hs-sites.com/we-are-acutis) - [Guiding Principles](https://acutis-21140295.hs-sites.com/guiding-principles) - [Compliance](https://acutis-21140295.hs-sites.com/en/compliance) - [Accreditations](https://acutis-21140295.hs-sites.com/accreditations) - [Careers](https://acutis-21140295.hs-sites.com/careers) - [Continuing Education](https://acutis-21140295.hs-sites.com/webinars-symposium) - Providers - [Infectious Diseases](https://acutis-21140295.hs-sites.com/molecular-tests-infectious-disease) - [Respiratory Pathogen Testing](https://acutis-21140295.hs-sites.com/rit-testing-respiratory-pathogen-tests) - [Gastrointestinal Pathogen Testing](https://acutis-21140295.hs-sites.com/git-testing-gastrointestinal-pathogens-testing) - [Urinary Tract Infection Testing](https://acutis-21140295.hs-sites.com/urinary-tract-infection-testing) - [Sexually Transmitted Infections](https://acutis-21140295.hs-sites.com/sti-testing) - [Pharyngeal Testing](https://acutis-21140295.hs-sites.com/pit-testing-strep-a) - [Clinical Toxicology](https://acutis-21140295.hs-sites.com/clinical-toxicology) - [Medication Monitoring](https://acutis-21140295.hs-sites.com/medication-monitoring-tests) - [Substance Use & Addiction](https://acutis-21140295.hs-sites.com/substance-use-and-addiction) - Patients - [Make a Payment](https://acutis-21140295.hs-sites.com/make-a-payment-as-patient) - [Financial Assistance](https://acutis-21140295.hs-sites.com/patient-financial-assistance) - [FAQs](https://info.acutis.com/patient-faqs) - [Insights](https://blog.acutis.com) - [Contact](https://acutis-21140295.hs-sites.com/contact) CONTACT PHONE HOTLINE: [844-522-8847](tel:+1844-522-8847)E-MAIL: [service@acutis.com](mailto:service@acutis.com) [i-Acutis](https://acutis.careevolve.com/doctors/framepage.asp) [![logo](https://blog.acutis.com/hubfs/logo-Acutis%20HD-2.webp "logo")](https://www.acutis.com/) - About - [What is Acutis?](https://acutis-21140295.hs-sites.com/what-is-acutis) - [Our Team](https://acutis-21140295.hs-sites.com/we-are-acutis) - [Guiding Principles](https://acutis-21140295.hs-sites.com/guiding-principles) - [Compliance](https://acutis-21140295.hs-sites.com/en/compliance) - [Accreditations](https://acutis-21140295.hs-sites.com/accreditations) - [Careers](https://acutis-21140295.hs-sites.com/careers) - [Continuing Education](https://acutis-21140295.hs-sites.com/webinars-symposium) - Providers - [Infectious Diseases](https://acutis-21140295.hs-sites.com/molecular-tests-infectious-disease) - [Respiratory Pathogen Testing](https://acutis-21140295.hs-sites.com/rit-testing-respiratory-pathogen-tests) - [Gastrointestinal Pathogen Testing](https://acutis-21140295.hs-sites.com/git-testing-gastrointestinal-pathogens-testing) - [Urinary Tract Infection Testing](https://acutis-21140295.hs-sites.com/urinary-tract-infection-testing) - [Sexually Transmitted Infections](https://acutis-21140295.hs-sites.com/sti-testing) - [Pharyngeal Testing](https://acutis-21140295.hs-sites.com/pit-testing-strep-a) - [Clinical Toxicology](https://acutis-21140295.hs-sites.com/clinical-toxicology) - [Medication Monitoring](https://acutis-21140295.hs-sites.com/medication-monitoring-tests) - [Substance Use & Addiction](https://acutis-21140295.hs-sites.com/substance-use-and-addiction) - Patients - [Make a Payment](https://acutis-21140295.hs-sites.com/make-a-payment-as-patient) - [Financial Assistance](https://acutis-21140295.hs-sites.com/patient-financial-assistance) - [FAQs](https://info.acutis.com/patient-faqs) - [Insights](https://blog.acutis.com) - [Contact](https://acutis-21140295.hs-sites.com/contact) PHONE HOTLINE: [844-522-8847](tel:+1844-522-8847)E-MAIL: [service@acutis.com](mailto:service@acutis.com) [i-Acutis](https://acutis.careevolve.com/doctors/framepage.asp) ![blog-FDA approves first Respiratory Syncytial Virus (RSV) Vaccine copy 2](https://blog.acutis.com/hs-fs/hubfs/blog-FDA%20approves%20first%20Respiratory%20Syncytial%20Virus%20(RSV)%20Vaccine%20copy%202.jpg?width=300&name=blog-FDA%20approves%20first%20Respiratory%20Syncytial%20Virus%20(RSV)%20Vaccine%20copy%202.jpg) [Batu Sharma, PhD](https://blog.acutis.com/author/batu-sharma-phd)May 16, 2023 2:22:00 AM1 min read # FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine | FDA [Previous](https://blog.acutis.com/drug-resistant-gonorrhea-is-no-match-for-a-new-class-of-antibiotics) [Next](https://blog.acutis.com/a-pseudomonas-aeruginosa-pqs-quorum-sensing-system-inhibitor-with-anti-staphylococcal-activity-sensitizes-polymicrobial-biofilms-to-tobramycin-sciencedirect-1) Respiratory Syncytial Virus (RSV) is a common respiratory virus that usually causes mild, cold-like symptoms, but can be serious for infants and older adults, resulting in an average of 60,000-160,000 hospitalizations and around 600-10,000 deaths per year in the US, with the highest death in people over 65. There is great news that on May 3, 2023, FDA approved the world’s first RSV vaccine for use in people aged 60 and older. Results from an ongoing, randomized, placebo-controlled clinical trial conducted globally among approximately 12,500 participants 60 years and older who received a single dose of the vaccine showed that the vaccine significantly reduced the risk of developing RSV-associated lower respiratory tract disease (LRTD) by 82.6% and reduced the risk of developing severe RSV-associated LRTD by 94.1%.  While FDA is expected to approve another RSV vaccine for older people later in May and another vaccine for pregnant people that also protects their newborns is under review by the FDA, the most important thing to lower the mortality associated with RSV is to diagnose it promptly to rule out other less severe respiratory illnesses using [diagnostic tests like Acutis Reveal™ RIT](https://www.acutis.com/rit-testing-respiratory-pathogen-tests)and treat it appropriately. **Read the full article >> [here](https://www.fda.gov/news-events/press-announcements/fda-approves-first-respiratory-syncytial-virus-rsv-vaccine)** ![avatar](https://blog.acutis.com/hs-fs/hubfs/Dr.%20Batu%20Author%20Icon.png?width=290&name=Dr.%20Batu%20Author%20Icon.png) #### [Batu Sharma, PhD](https://blog.acutis.com/author/batu-sharma-phd) Experienced Medical/Scientific Writer working in Vaccines/Antimicrobial Drug/Device/Diagnostics ## RELATED ARTICLES [![Acutis-white](https://info.acutis.com/hs-fs/hubfs/Acutis-white.png?width=100&name=Acutis-white.png)](https://www.acutis.com/) **Insights. Answers. Outcomes. ** **Diagnostic Excellence. **   400 Karin Lane | Hicksville, NY 11801 68 Culver Road, Monmouth Junction, NJ 08852 - About - [What is Acutis?](https://acutis-21140295.hs-sites.com/what-is-acutis) - [Accreditations](https://acutis-21140295.hs-sites.com/accreditations) - [Payer Relations](https://acutis-21140295.hs-sites.com/payer-relations-information) - [Careers](https://acutis-21140295.hs-sites.com/careers) - [Insights](https://blog.acutis.com) - [Contact](https://acutis-21140295.hs-sites.com/contact) - [HIPAA Privacy](https://acutis-21140295.hs-sites.com/en/hippa-privacy) - [Privacy Practices](https://blog.acutis.com/hubfs/2022%20Notice%20of%20Privacy%20Practices.pdf?hsLang=en) - [Privacy Policy](https://info.acutis.com/privacy-policy) - [SMS Terms and Conditions](https://acutis-21140295.hs-sites.com/sms-terms-conditions) - Providers - [Make a Payment](https://acutis-21140295.hs-sites.com/physician-practice-payment) - [Test Menus](https://acutis-21140295.hs-sites.com/test-menus) - [Arrange Sample Pick-up](https://acutis-21140295.hs-sites.com/physician-practice-sample-pick-up) - [Order POC Cups](https://acutisdiagnostics.myshopify.com/products/bluerapids-concise-12-panel-cup) - [Order Supplies](https://acutis-21140295.hs-sites.com/physician-practice-order-supplies) - Infectious Diseases - Clinical Toxicology - [Annual Physicians Notice](https://www.acutis.com/hubfs/2022%20Annual%20Physician%20Notice.pdf) - [Provider FAQs](https://info.acutis.com/general-faqs) - Patients - [Patient Payment Link](https://acutis-21140295.hs-sites.com/make-a-payment-as-patient) - [Patient FAQs](https://info.acutis.com/patient-faqs) - [Patient Financial Assistance](https://acutis-21140295.hs-sites.com/patient-financial-assistance) - [Biopharma](https://biosciences.acutis.com) - [Oncology](https://biosciences.acutis.com/oncology) - [Infectious Disease](https://biosciences.acutis.com/infectious-disease) All rights reserved | THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE. The information on this website is not intended to substitute for or be relied upon as medical advice, diagnosis, or treatment. This website is for informational purposes only. Always seek the advice of your physician or other qualified health providers with any questions you may have regarding a medical condition.© 2026 Acutis Diagnostics ```json { "@context" : "https://schema.org", "@type" : "Organization", "address" : { "@type" : "PostalAddress", "addressCountry" : "", "addressLocality" : "Hicksville", "addressRegion" : "NY", "postalCode" : "11801", "streetAddress" : "400 Karin Lane" }, "email" : "service@acutis.com", "knowsLanguage" : "en", "logo" : { "@type" : "ImageObject", "url" : "https://f.hubspotusercontent40.net/hubfs/21140295/logo-Acutis%20HD-2.webp" }, "name" : "Acutis Diagnostics Inc.", "telephone" : "844-522-8847", "url" : "https://blog.acutis.com/fda-approves-first-respiratory-syncytial-virus-rsv-vaccine-fda" } ``` ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "abstract" : "On May 3, 2023, FDA approved the world’s first RSV vaccine for use in people aged 60 and older. Read more about promising news for infants and older adults", "author" : { "@type" : "Person", "name" : "Batu Sharma, PhD" }, "dateModified" : "May 16, 2023 6 AM", "datePublished" : "May 16, 2023 6 AM", "headline" : "FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine | FDA", "image" : "https://info.acutis.com/hubfs/blog-FDA%20approves%20first%20Respiratory%20Syncytial%20Virus%20%28RSV%29%20Vaccine%20copy%202.jpg", "inLanguage" : "en", "keywords" : "[EDUCATION]", "mainEntityOfPage" : { "@type" : "WebPage" }, "name" : "FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine | FDA", "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://f.hubspotusercontent40.net/hubfs/21140295/logo-Acutis%20HD-2.webp" }, "name" : "Acutis Diagnostics Inc." }, "text" : "Respiratory Syncytial Virus (RSV) is a common respiratory virus that usually causes mild, cold-like symptoms, but can be serious for infants and older adults, resulting in an average of 60,000-160,000 hospitalizations and around 600-10,000 deaths per year in the US, with the highest death in people over 65. There is great news that on May 3, 2023, FDA approved the world’s first RSV vaccine for use in people aged 60 and older. Results from an ongoing, randomized, placebo-controlled clinical trial conducted globally among approximately 12,500 participants 60 years and older who received a single dose of the vaccine showed that the vaccine significantly reduced the risk of developing RSV-associated lower respiratory tract disease (LRTD) by 82.6% and reduced the risk of developing severe RSV-associated LRTD by 94.1%. While FDA is expected to approve another RSV vaccine for older people later in May and another vaccine for pregnant people that also protects their newborns is under review by the FDA, the most important thing to lower the mortality associated with RSV is to diagnose it promptly to rule out other less severe respiratory illnesses using diagnostic tests like Acutis Reveal™ RIT and treat it appropriately. Read the full article >> here", "url" : "https://blog.acutis.com/fda-approves-first-respiratory-syncytial-virus-rsv-vaccine-fda", "wordCount" : "290" } ``` ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "Batu Sharma, PhD", "url" : "https://blog.acutis.com/author/batu-sharma-phd" }, "dateModified" : "2023-05-16T06:22:00.812Z", "datePublished" : "2023-05-16T06:22:00.000Z", "headline" : "FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine | FDA", "image" : [ "https://blog.acutis.com/hubfs/blog-FDA%20approves%20first%20Respiratory%20Syncytial%20Virus%20(RSV)%20Vaccine%20copy%202.jpg" ], "mainEntityOfPage" : { "@id" : "https://blog.acutis.com/fda-approves-first-respiratory-syncytial-virus-rsv-vaccine-fda", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://blog.acutis.com/hubfs/logo-Acutis%20HD-2.webp" }, "name" : "Acutis Diagnostics Inc. | Acutis Biosciences" } } ```